TG Therapeutics | TGTX - Beneficio Operativo

Precio De Mercado
30.23
Cambio Diario
-0.22 -0.72%
Mensual
1.92%
Anual
-29.37%
Q1 Expectativa
29.17




Beneficio Operativo Cambio Fecha
AbbVie USD 5.81B 1.23B 2025-12
Alaunos Therapeutics USD -1.19M 148K 2025-09
Amgen USD 3.96B 464M 2025-12
Ardelyx USD 5.1M 431K 2025-12
Arrowhead Research USD 40.81M 3.3M 2025-12
Bayer EUR 1.11B 1.65B 2025-12
Biogen USD 659.6M 192.2M 2025-09
Corcept Therapeutics USD 4.49M 5.73M 2025-12
Curis USD -12.51M 40K 2024-06
Gilead Sciences USD 2.96B 551M 2025-12
Infinity Pharmaceuticals USD -10.12M 1.39M 2023-06
J&J USD 5.59B 1.81B 2025-12
Karyopharm Therapeutics USD -31.28M 5M 2024-12
Novartis USD 4.06B 437M 2025-12
Novavax USD 20.94M 100.32M 2025-12
PTC Therapeutics USD -81.62M 85.11M 2025-12
Puma Biotechnology USD 22.08M 24.26M 2024-09
Regeneron Pharmaceuticals USD 898.6M 211.3M 2025-12
Roche Holding CHF 9.56B 3.8B 2025-12
TG Therapeutics USD 50.49M 21.13M 2025-12
Verastem USD -18.28M 9.78M 2024-06
Vertex Pharmaceuticals USD 1.26B 24.5M 2025-12